James Rocco, MD, PhD
College of Medicine
Dr. Rocco focuses on the surgical care and regular surveillance of the head and neck cancer patient. He is also experienced in helping select head and neck cancer patients to participate with ongoing clinical trials. Dr. Rocco leads an active NIH/NIDCR R01-funded research effort that is focused on identifying biomarkers of clinical outcome in head and neck squamous cell carcinoma. Here Dr. Rocco is examining the functional role of the anti-apoptotic cell death protein Bcl2 after platinum-based chemo-radiotherapy on tumor response and the impact of intra-tumor heterogeneity as measured by next generation sequencing methods on patient survival.